Neurology Disorder Diagnosis Articles & Analysis
3 news found
NeuroPointDX, a business unit of Stemina Biomarker Discovery, today announced the company will present recent data from the Children’s Autism Metabolome Project (CAMP), its large, comprehensive clinical study, supporting its precision medicine approach to the diagnosis and treatment of autism spectrum disorder (ASD) at the National TACA Autism Conference. ...
“While biomarkers of any kind cannot provide a definitive diagnosis of ASD, combining a metabolomics-based screen with behavioral testing increases the likelihood that those at risk for ASD can be detected as early as ...
Stratifying ASD based on metabotypes both offers an opportunity for earlier identification of children at risk for an ASD diagnosis, as well as a potential strategy for more precise and individualized treatment of some affected children. ...